V L Kan

1.0k total citations · 1 hit paper
6 papers, 763 citations indexed

About

V L Kan is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, V L Kan has authored 6 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Cell Biology. Recurrent topics in V L Kan's work include Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Plant Pathogens and Fungal Diseases (2 papers). V L Kan is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers) and Plant Pathogens and Fungal Diseases (2 papers). V L Kan collaborates with scholars based in United States and United Kingdom. V L Kan's co-authors include John E. Bennett, George A. Pankey, D. A. Stevens, Thomas J. Walsh, Stephen Dummer, Thomas F. Patterson, David W. Denning, Marc A. Judson, V. A. Morrison and Michael Amantea and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

V L Kan

6 papers receiving 704 citations

Hit Papers

Practice Guidelines for Diseases Caused by Aspergillus 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V L Kan United States 6 617 515 132 96 60 6 763
J W Lee United States 11 647 1.0× 496 1.0× 130 1.0× 79 0.8× 63 1.1× 13 767
Peggy Miniter United States 17 574 0.9× 449 0.9× 161 1.2× 50 0.5× 55 0.9× 23 775
C A Lyman United States 17 578 0.9× 473 0.9× 99 0.8× 57 0.6× 68 1.1× 23 775
Amy M. Kelaher United States 13 724 1.2× 588 1.1× 132 1.0× 85 0.9× 43 0.7× 15 827
Peter Francis United States 7 508 0.8× 377 0.7× 80 0.6× 59 0.6× 102 1.7× 9 613
W. Lau United States 7 845 1.4× 708 1.4× 200 1.5× 113 1.2× 66 1.1× 9 893
Richard J. Fetchick United States 9 382 0.6× 321 0.6× 112 0.8× 41 0.4× 54 0.9× 10 549
Alayn R. Waldorf United States 9 524 0.8× 355 0.7× 115 0.9× 48 0.5× 28 0.5× 11 630
Sumio Kawamura Japan 11 304 0.5× 290 0.6× 51 0.4× 66 0.7× 70 1.2× 22 586
Branch T. Fields United States 9 628 1.0× 615 1.2× 73 0.6× 30 0.3× 65 1.1× 12 872

Countries citing papers authored by V L Kan

Since Specialization
Citations

This map shows the geographic impact of V L Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V L Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V L Kan more than expected).

Fields of papers citing papers by V L Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V L Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V L Kan. The network helps show where V L Kan may publish in the future.

Co-authorship network of co-authors of V L Kan

This figure shows the co-authorship network connecting the top 25 collaborators of V L Kan. A scholar is included among the top collaborators of V L Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V L Kan. V L Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Stevens, D. A., V L Kan, Marc A. Judson, et al.. (2000). Practice Guidelines for Diseases Caused by Aspergillus. Clinical Infectious Diseases. 30(4). 696–709. 581 indexed citations breakdown →
2.
Kan, V L, Antonia Geber, & John E. Bennett. (1996). Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion. Antimicrobial Agents and Chemotherapy. 40(7). 1717–1719. 22 indexed citations
3.
Kan, V L, John E. Bennett, Michael Amantea, et al.. (1991). Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers. The Journal of Infectious Diseases. 164(2). 418–421. 84 indexed citations
4.
Kan, V L & John E. Bennett. (1988). Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrobial Agents and Chemotherapy. 32(11). 1619–1623. 45 indexed citations
5.
Kan, V L, David K. Henderson, & John E. Bennett. (1986). Bioassay for SF 86-327, a new antifungal agent. Antimicrobial Agents and Chemotherapy. 30(4). 628–629. 13 indexed citations
6.
Henderson, David K., V L Kan, & John E. Bennett. (1986). Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro.. PubMed. 65(3). 639–46. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026